Skip to content

Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine

Evaluation of the Treatment Satisfaction in Children Suffering From an Allergy and Who Received an Antihistamine Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00453583
Enrollment
4581
Registered
2007-03-29
Start date
2007-03-31
Completion date
2008-01-31
Last updated
2013-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergies

Keywords

Pediatric, Allergies, Antihistamines, Non-interventional

Brief summary

This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.

Interventions

None listed

Sponsors

UCB Pharma
Lead SponsorINDUSTRY

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children from 2-12 included * History of allergy * Used an Antihistamine within market authorization

Exclusion criteria

* Child not yet treated for the presented allergy

Design outcomes

Primary

MeasureTime frame
Parent satisfaction on a 11-point scaleduration of the study

Secondary

MeasureTime frame
Physician satisfaction on an 11-point scaleduration of the study
Efficacy, tolerability and global satisfactionduration of the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026